Equifax Inc.

(New York Stock Exchange)

Top News rankings and signal summaries are processed using AI and may contain errors.

21
Slightly Bearish -15

Stay Ahead of the Game With Equifax (EFX) Q3 Earnings: Wall Street's Insights on Key Metrics

Earnings report AI-generated analysis

Wall Street analysts project Equifax (EFX) to report quarterly earnings of $2.20 per share, representing a 7.8% year-over-year increase, with revenues estimated at $1.69 billion, up 9.6% from the prior-year quarter. However, consensus EPS estimates have seen a downward revision of 0.4% over the last...

Bullish Signals

  • Analysts project quarterly earnings of $2.20/share, up 7.8%.
  • Revenue forecast reaches $1.69 billion, a 9.6% growth.
  • Workforce Solutions revenue estimated at $703.66 million, up 8.4%.
  • U.S. Information Solutions revenue projected at $535.08 million, up 14.5%.
  • Asia Pacific operating revenue expected to grow 10.4% to $99.49M.

Bearish Signals

  • Consensus EPS estimates revised down 0.4% in last 30 days.
  • Shares declined 8.2% over past month, underperforming S&P 500.
  • Stock carries Zacks Rank #4 (Sell), expecting market lag.
22
Bearish -65

Equifax Inc Stock (EFX) Moved Down by 7.02% on Sep 4: Facts Behind the Movement - TradingKey

AI-generated analysis

Equifax Inc (EFX) shares fell 7.02% on September 4, driven primarily by regulatory risks and a potential structural shift in mortgage reporting requirements. The Federal Housing Finance Agency (FHFA) is evaluating a move from the traditional tri-merge credit reporting model to a bi-merge framework for...

Bullish Signals

  • Analysts maintain Buy ratings with $210.69 average price target.
  • Diversified segments buffer against domestic mortgage volatility.

Bearish Signals

  • FHFA bi-merge model threatens recurring revenue from Fannie Mae and Freddie Mac.
23
Bearish -65

Equifax Inc Stock (EFX) Moved Down by 7.02% on Sep 4: Facts Behind the Movement - TradingKey

AI-generated analysis

Equifax Inc (EFX) shares fell 7.02% on September 4, driven by significant regulatory headwinds and insider selling pressure. The primary catalyst was a structural shift in mortgage reporting requirements proposed by the Federal Housing Finance Agency (FHFA), which is evaluating a move from a tri-merge...

Bullish Signals

  • Workforce Solutions and international data buffer domestic mortgage risks.
  • Analysts rate Buy with $210.69 price target.

Bearish Signals

  • Mortgage volume imperiled by shift to bi-merge reporting.
  • VantageScore 4.0 mandate threatens traditional scoring structures.
  • CFO sold $845k shares, amplifying negative sentiment.
24
Somewhat Bullish +50

EFX: Equifax Gives TALX Shareholders the Illusion of Choice

AI-generated analysis

Equifax (EFX) has agreed to acquire Talx Corp. (TALX), a provider of HR, payroll, and employment verification services, in a deal expected to close by the end of the second quarter or early third quarter pending regulatory and shareholder approvals. Under the terms of the...

Bullish Signals

  • Acquired Talx Corp. to expand HR and payroll outsourcing.
  • Deal structure limits dilution risk without expensive financing.

Bearish Signals

  • Acquisition creates 22M new shares causing shareholder dilution.
25
Neutral +10

Equifax (EFX) Projected to Post Earnings on Tuesday - American Market News

AI-generated analysis

Equifax (NYSE: EFX) is scheduled to announce its Q2 2026 earnings results before the market opens on Tuesday, July 21st. Analysts project earnings per share of $2.21 and revenue of $1.6968 billion. The company has provided guidance for Q2 EPS between $2.15 and $2.25, with...

Bullish Signals

  • Q1 revenue grew 14.3% to $1.65 billion.
  • Return on equity reached 20.41% with 11.12% net margin.
  • Institutional ownership stands high at 96.20%.
  • Ameriflex Group increased position by 612.5%.

Bearish Signals

  • Stock trades below 200-day moving average of $185.33 at $172.62.
  • Analysts lowered targets: Bank of America ($250 to $225) and Mizuho ($222 to $210).
  • CEO sold 37,791 shares, reducing stake by 12.21% in April.
  • BNP Paribas Exane downgraded target to $185 with neutral rating.